Journal
METHODS
Volume 211, Issue -, Pages 10-22Publisher
ACADEMIC PRESS INC ELSEVIER SCIENCE
DOI: 10.1016/j.ymeth.2023.02.001
Keywords
De novo drug design; Deep molecular generative model; GAN; Drug-like; Binding affinity
Ask authors/readers for more resources
Deep learning has greatly improved and changed the process of de novo molecular design. The proposed DNMG model utilizes a deep generative adversarial network combined with transfer learning to consider the 3D spatial information and physicochemical properties of molecules, generating valid and novel drug-like ligands. The computational results demonstrate that the molecules generated by DNMG have better binding ability and physicochemical properties for target proteins.
Deep learning is improving and changing the process of de novo molecular design at a rapid pace. In recent years, great progress has been made in drug discovery and development by using deep generative models for de novo molecular design. However, most of the existing methods are string-based or graph-based and are limited by the lack of some very important properties, such as the three-dimensional information of molecules. We propose DNMG, a deep generative adversarial network (GAN) combined with transfer learning. Specifically, we use a Wasserstein-variant GAN based network architecture that considers the 3D grid spatial information of the ligand with atomic physicochemical properties to generate a representation of the molecule, which is then parsed into SMILES strings using an improved captioning network. Comprehensive in experiments demonstrate the ability of DNMG to generate valid and novel drug-like ligands. The DNMG model is used to design inhibitors for three targets, MK14, FNTA, and CDK2. The computational results show that the molecules generated by DNMG have better binding ability to the target proteins and better physicochemical properties. Overall, our deep generative model has excellent potential to generate molecules with high binding affinity for targets and explore the space of drug-like chemistry.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available